Skip to content
10-Q

Quarterly Report

Cell Source, Inc. CLCS

0001493152-24-029448

← back to feed
Filed
Jul 29, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Jul 23, 2024 41.94M sh
Total Liabilities Q1 2024 · Mar 31, 2024 $16.84M
Total Liabilities Q1 2024 · Dec 31, 2023 $15.81M
Total Assets Q1 2024 · Mar 31, 2024 $82.59K
Total Assets Q1 2024 · Dec 31, 2023 $195.17K
Shares Diluted Q1 2024 · Mar 31, 2023 37.06M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$309.61K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$14.22M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$12.63M
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.05
Eps Basic Q1 2024 · Mar 31, 2023 −$0.05
Net Income Q1 2024 · Mar 31, 2023 −$1.69M
Operating Income Q1 2024 · Mar 31, 2023 −$1.42M